WallStreetZenWallStreetZen

NASDAQ: BCTX
Briacell Therapeutics Corp Stock

$7.12+0.20 (+2.89%)
Updated Mar 29, 2023
BCTX Price
$7.12
Fair Value Price
$9.28
Market Cap
$110.49M
52 Week Low
$4.06
52 Week High
$12.09
P/E
-3.15x
P/B
-86.28x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$35.01M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-27.68
Operating Cash Flow
-$17M
Beta
1.22
Next Earnings
Mar 30, 2023
Ex-Dividend
N/A
Next Dividend
N/A

BCTX Overview

BriaCell Therapeutics Corp. develops immunotherapies for the treatment of cancer. Its lead candidate, Bria-IMT, is in Phase I/IIa clinical trials for the treatment of breast cancer. The company has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, personalized immunotherapy for advanced breast cancer, and BriaDx, a diagnostic test. BriaCell Therapeutics is headquartered in West Vancouver, Canada.

Zen Score

Industry Average (25)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BCTX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BCTX ($7.12) is undervalued by 23.27% relative to our estimate of its Fair Value price of $9.28 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
BCTX ($7.12) is significantly undervalued by 23.27% relative to our estimate of its Fair Value price of $9.28 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
BCTX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more BCTX due diligence checks available for Premium users.

Be the first to know about important BCTX news, forecast changes, insider trades & much more!

BCTX News

Valuation

BCTX fair value

Fair Value of BCTX stock based on Discounted Cash Flow (DCF)
Price
$7.12
Fair Value
$9.28
Undervalued by
23.27%
BCTX ($7.12) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BCTX ($7.12) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BCTX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

BCTX price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.15x
Industry
18.17x
Market
21.81x

BCTX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-86.28x
Industry
4.92x

BCTX's financial health

Profit margin

Revenue
$0.0
Net Income
-$11.9M
Profit Margin
0%
BCTX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$34.2M
Liabilities
$35.4M
Debt to equity
-27.68
BCTX's short-term assets ($33.94M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BCTX's long-term liabilities ($34.77M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BCTX's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BCTX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.0M
Investing
$0.0
Financing
$0.0
BCTX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

BCTX vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
BCTX$110.49M+2.89%-3.15x-86.28x
GNTA$111.12M+8.93%-28.24x3.06x
LMNL$109.58M-5.36%30.43x4.18x
AKBA$111.47M+1.00%-1.19x11.93x
CMRX$109.46M+4.20%0.63x0.43x

Briacell Therapeutics Stock FAQ

What is Briacell Therapeutics's quote symbol?

NASDAQ: BCTX) Briacell Therapeutics trades on the NASDAQ under the ticker symbol BCTX. Briacell Therapeutics stock quotes can also be displayed as NASDAQ: BCTX.

If you're new to stock investing, here's how to buy Briacell Therapeutics stock.

What is the 52 week high and low for Briacell Therapeutics (NASDAQ: BCTX)?

(NASDAQ: BCTX) Briacell Therapeutics's 52-week high was $12.09, and its 52-week low was $4.06. It is currently -41.11% from its 52-week high and 75.37% from its 52-week low.

How much is Briacell Therapeutics stock worth today?

(NASDAQ: BCTX) Briacell Therapeutics currently has 15,518,018 outstanding shares. With Briacell Therapeutics stock trading at $7.12 per share, the total value of Briacell Therapeutics stock (market capitalization) is $110.49M.

Briacell Therapeutics stock was originally listed at a price of $3.90 in Feb 24, 2021. If you had invested in Briacell Therapeutics stock at $3.90, your return over the last 2 years would have been 82.56%, for an annualized return of 35.12% (not including any dividends or dividend reinvestments).

How much is Briacell Therapeutics's stock price per share?

(NASDAQ: BCTX) Briacell Therapeutics stock price per share is $7.12 today (as of Mar 29, 2023).

What is Briacell Therapeutics's Market Cap?

(NASDAQ: BCTX) Briacell Therapeutics's market cap is $110.49M, as of Mar 30, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Briacell Therapeutics's market cap is calculated by multiplying BCTX's current stock price of $7.12 by BCTX's total outstanding shares of 15,518,018.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.